Abstract
PHLPP (PH domain leucine-rich repeats protein phosphatase) represents a family of novel Ser/Thr protein phosphatases. Two highly related isoforms in this family, PHLPP1 and PHLPP2, have been identified to serve as negative regulators of Akt and protein kinase C by dephosphorylating the kinases directly. In this study, we examined the expression pattern of both PHLPP isoforms in colorectal cancer specimens and the adjacent normal mucosa using immunohistochemical staining. We found that the expression of PHLPP1 or PHLPP2 isoform was lost or decreased in 78 and 86% of tumor tissues, respectively. Stable overexpression of either PHLPP isoform in colon cancer cells decreased the rate of cell proliferation and sensitized the cells to growth inhibition induced by the phosphoinositide-3 kinase inhibitor, LY294002, whereas knockdown of either PHLPP isoform by shRNA promoted the proliferation of DLD1 cells. In addition, we demonstrated that the PHLPP-mediated growth inhibition in colon cancer cells was largely rescued by overexpression of a constitutively active Akt. Moreover, reexpression of either PHLPP isoform in HCT116 cells inhibited tumor growth in vivo. Taken together, our results strongly support a tumor suppressor role of PHLPP in colon cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brognard J, Sierecki E, Gao T, Newton AC . (2007). PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25: 917–931.
Gao T, Brognard J, Newton AC . (2008). The phosphatase PHLPP controls the cellular levels of protein kinase C. J Biol Chem 283: 6300–6311.
Gao T, Furnari F, Newton AC . (2005). PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18: 13–24.
Gokmen-Polar Y, Murray NR, Velasco MA, Gatalica Z, Fields AP . (2001). Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res 61: 1375–1381.
Hershko DD, Shapira M . (2006). Prognostic role of p27Kip1 deregulation in colorectal cancer. Cancer 107: 668–675.
Kosinski C, Li VSW, Chan ASY, Zhang J, Ho C, Tsui WY et al. (2007). Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci 104: 15418–15423.
Liang J, Slingerland JM . (2003). Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2: 339–345.
Manning BD, Cantley LC . (2007). AKT/PKB signaling: navigating downstream. Cell 129: 1261–1274.
Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC . (2005). Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev 19: 1773–1778.
Maroulakou IG, Oemler W, Naber SP, Tsichlis PN . (2007). Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res 67: 167–177.
Murray NR, Davidson LA, Chapkin RS, Clay Gustafson W, Schattenberg DG, Fields AP . (1999). Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. J Cell Biol 145: 699–711.
Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S et al. (2004). Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 6: 661–672.
Newton AC . (2003). Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 370: 361–371.
Qiao M, Iglehart JD, Pardee AB . (2007). Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation. Cancer Res 67: 5293–5299.
Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, Jakesz R . (1990). Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 50: 7057–7061.
Rosner M, Freilinger A, Hengstschlager M . (2006). The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27. Mutat Res 613: 10–16.
Saaf AM, Halbleib JM, Chen X, Yuen ST, Leung SY, Nelson WJ et al. (2007). Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mol Biol Cell 18: 4245–4260.
Samuels Y, Diaz Jr LA, Schmidt-Kittler O, Cummins JM, Delong L, Cheong I et al. (2005). Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7: 561–573.
Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.
Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS et al. (2003). Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9: 493–501.
Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A . (2005). Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20: 539–550.
Acknowledgements
We thank UTMB flow cytometry core for assistance with the flow cytometry analysis, and Dr Alexandra Newton at University of California San Diego for providing the wild-type and mutant Akt and PKC βII expression constructs. This work was supported by NIH K01 CA10209-05 (TG), American Cancer Society RSG0822001TBE (TG) and R01CA104748 (BME).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Rights and permissions
About this article
Cite this article
Liu, J., Weiss, H., Rychahou, P. et al. Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis. Oncogene 28, 994–1004 (2009). https://doi.org/10.1038/onc.2008.450
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.450
Keywords
This article is cited by
-
Inhibition of mitochondrial fission activates glycogen synthesis to support cell survival in colon cancer
Cell Death & Disease (2023)
-
Loss of pleckstrin homology domain and leucine-rich repeat protein phosphatase 2 has protective effects on high glucose-injured retinal ganglion cells via the effect on the Akt–GSK–3β–Nrf2 pathway
Inflammation Research (2023)
-
MiR-509-3p is oncogenic, targets the tumor suppressor PHLPP2, and functions as a novel tumor adjacent normal tissue based prognostic biomarker in colorectal cancer
BMC Cancer (2022)
-
Activation of Drp1 promotes fatty acids-induced metabolic reprograming to potentiate Wnt signaling in colon cancer
Cell Death & Differentiation (2022)
-
MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2
Clinical and Translational Oncology (2022)